Susan G. Komen Breast Cancer Foundation   Report issue

Foundation Phase 1 Phase 2
Founded: Dallas TX United States (1982)

Organization Overview

First Clinical Trial
1998
NCT01204957
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Susan G. Komen Breast Cancer Foundation